SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ACADIA Pharmaceuticals Inc. – ACAD
On March 8, 2021, post-market, Acadia issued a press release providing a regulatory update on the Company’s supplemental New Drug …
Discussion disabled.
Category: Dementia